WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer

Cancer Research

Volumn 63, Issue 4, 2003, Pages 878-881

  Yendamuri, Sai ^a   Kuroki, Tamotsu ^a   Trapasso, Francesco ^a   Henry, Adam C ^b   Dumon, Kristoffel R ^b   Huebner, Kay ^a   Williams, Noel N ^b   Kaiser, Larry R ^b   Croce, Carlo M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN; GENE PRODUCT; ONCOPROTEIN; TOBACCO SMOKE; UNCLASSIFIED DRUG; WW DOMAIN CONTAINING OXIDOREDUCTASE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CARCINOGENESIS; CHROMOSOME 16Q; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGUS CANCER; EXON; GENE EXPRESSION; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENE TARGETING; GENETIC TRANSCRIPTION; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; NUCLEOTIDE SEQUENCE; ONCOGENE; OVARY CANCER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WW DOMAIN CONTAINING OXIDOREDUCTASE GENE;

CARCINOMA, NON-SMALL-CELL LUNG; CARRIER PROTEINS; GENE DELETION; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; NEOPLASM PROTEINS; OXIDOREDUCTASES; POINT MUTATION; PROTEIN STRUCTURE, TERTIARY; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0037442728     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Greenlee, R. T., Hill-Harmon, M. B., Murray, T., and Thun, M. Cancer statistics, 2001. CA - Cancer J. Clin., 51: 15-36, 2001.
2. Kim, T. E., and Murren, J. R. Therapy for Stage IIIB and Stage IV non-small cell lung cancer. Clin. Chest Med., 23: 209-224, 2002.
3. Inoue, H., Ishii, H., Alder, H., Snyder, E., Druck, T,. Huebner, K., and Croce, C. M. Sequence of the FRA3B common fragile region: implications for the mechanism of FHIT deletion. Proc. Natl. Acad. Sci. USA. 94: 14584-14589, 1997.
4. Mori, M., Mimori, K., Shiraishi, T., Alder, H., Inoue, H., Tanaka, Y., Sugimachi, K., Huebner, K., and Croce, C. M. Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus. Cancer Res., 60: 1177-1182, 2000.
5. Sozzi, G., Pastorino, U., Moiraghi, L., Tagliabue, E., Pezzella, F., Ghirelli, C., Tornielli, S., Sard, L., Huebner, K., Pierotti, M. A., Croce, C. M., and Pilotti, S. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res., 58: 5032-5037, 1998.
6. Ohta, M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa, R., Palazzo, J., Siprashvili, Z., Mori, M., McCue, P., Druck, T., et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell, 84: 587-597, 1996.
7. Ingvarsson, S., Agnarsson, B. A., Sigbjomsdottir, B. I., Kononen, J., Kallioniemi, O. P., Barkardottir, R. B., Kovatich, A. J., Schwarting, R., Hauck, W. W., Huebner, K., and McCue, P. A. Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas. Cancer Res., 59: 2682-2689, 1999.
8. Turner, B. C., Ottey, M., Zimonjic, D. B., Potoczek, M., Hauck, W. W., Pequignot, E., Keck-Waggoner, C. L., Sevignani, C., Aldaz, C. M., McCue, P. A., Palazzo, J., Huebner, K., and Popescu, N. C. The fragile histidine triad/common chromosome fragile site 3B locus and repair-deficient cancers. Cancer Res., 62: 4054-4060, 2002.
9. Mori, M., Mimori, K., Masuda, T., Yoshinaga, K., Yamashita, K., Matsuyama, A., and Inoue, H. Absence of Msh2 protein expression is associated with alteration in the FHIT locus and Fhit protein expression in coloreclat carcinoma. Cancer Res., 61: 7379-7382, 2001.
10. Bednarek, A. K., Laflin, K. J. Daniel, R. L., Liao, Q., Hawkins, K. A., and Aldaz, C. M. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res., 60: 2140-2145, 2000.
11. Driouch, K., Prydz, H., Monese, R., Johansen, H., Lidereau, R., and Frengen, E. Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors. Oncogene, 21: 1832-1840, 2002.
12. Kuroki, T., Trapasso, F., Shiraishi, T., Alder, H., Mimori, K., Mori, M., and Croce, C. M. Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma. Cancer Res., 62: 2258-2260, 2002.
13. Paige, A. J., Taylor, K. J., Taylor, C., Hillier, S. G., Farrington, S., Scott, D., Porteous, D. J., Smyth, J. F., Gabra, H., and Watson, J. E. WWOX: a candidate tumor suppressor gene involved in multiple tumor types. Proc. Natl. Acad. Sci. USA, 98: 11417-11422, 2001.
14. Druck, T., Hadaczek, P., Fu, T. B., Ohta, M., Siprashvili, Z., Baffa, R., Negrini, M., Kastury, K., Veronese, M. L., Rosen, D., Rothstein, J., McCue, P., Cotticelli, M. G., Inoue, H., Croce, C. M., and Huebner, K. Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res., 57: 504-512, 1997.
15. Fong, K. M., Biesterveld, E. J., Virmani, A., Wistuba, I., Sekido, Y., Bader, S. A., Ahmadian, M., Ong, S. T., Rassool, F. V., Zimmerman, P. V., Giaccone, G., Gazdar, A. F., and Minna, J. D. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Cancer Res., 57: 2256-2267, 1997.
16. Ishii, H., Baffa, R., Numata, S. I., Murakumo, Y., Rattan, S., Inoue, H., Mori, M., Fidanza, V., Alder, H., and Croce, C. M. The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors. Proc. Natl. Acad. Sci. USA, 96: 3928-3933, 1999.
17. Ried, K., Finnis, M., Hobson, L., Mangelsdorf, M., Dayan, S., Nancarrow, J. K., Woollatt, E., Kremmidiotis, G., Gardner, A., Venter, D., Baker, E., and Richards, R. I. Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum. Mol. Genet., 9: 1651-1663, 2000.
18. Zanesi, N., Fidanza, V., Fong, L. Y., Mancini, R., Druck, T., Valtieri, M., Rudiger, T., McCue, P. A., Croce, C. M., and Huebner, K. The tumor spectrum in FHIT-deficient mice. Proc. Natl. Acad. Sci. USA, 98: 10250-10255, 2001.
19. Philipp-Staheli, J., Payne, S. R., and Kemp, C. J. p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. Exp. Cell Res., 264: 148-168, 2001.
20. Bednarek, A. K., Keck-Waggoner, C. L., Daniel, R. L., Lafiin, K. J., Bergsagel, P. L., Kiguchi, K., Brenner, A. J., and Aldaz, C. M. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. Cancer Res., 61: 8068-8073, 2001.
21. Castellsague, X., Munoz, N., De Stefani, E., Victora, C. G., Castelletto, R., Rolon, P. A., and Quintana, M. J. Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women. Int. J. Cancer, 82: 657-664, 1999.
22. Morabia, A., and Wynder, E. L. Cigarette smoking and lung cancer cell types. Cancer (Phila.), 68: 2074-2078, 1991.